{"id":1635,"date":"2018-01-30T08:05:08","date_gmt":"2018-01-30T07:05:08","guid":{"rendered":"http:\/\/www.oxynov.com\/?p=1635\/"},"modified":"2026-01-30T18:50:36","modified_gmt":"2026-01-30T17:50:36","slug":"publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations","status":"publish","type":"post","link":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/","title":{"rendered":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO<sub>2<\/sub> in patients with COPD acute exacerbations"},"content":{"rendered":"<h2>25What\u00a0 is the FreeO<sub>2<\/sub>\u00a0value proposition for COPD exacerbation ?<\/h2>\n<h2><span style=\"color: #008ccc;\"><strong>Minus 21% in hospital cost of care (at 180days).<\/strong><\/span><\/h2>\n<p><strong><a href=\"http:\/\/bmjopen.bmj.com\/content\/8\/1\/e018835.info\"><span class=\"name\">Thomas G Poder<\/span>1<span class=\"xref-sep\">,<\/span>2,\u00a0<span class=\"name\">Christian R C Kouakou<\/span>2,\u00a0<span class=\"name\">Pierre-Alexandre Bouchard<\/span>3,\u00a0<span class=\"name\">V\u00e9ronique Tremblay<\/span>4,\u00a0<span class=\"name\">S\u00e9bastien Blais<\/span>4,\u00a0<span class=\"name\">Fran\u00e7ois Maltais<\/span>3,\u00a0<span class=\"name\">Fran\u00e7ois Lellouche<\/span>3. Cost-effectiveness of FreeO<sub>2<\/sub>\u00a0in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec.\u00a0<span class=\"highwire-cite-metadata-journal highwire-cite-metadata\">BMJ Open\u00a0<\/span><span class=\"highwire-cite-metadata-year highwire-cite-metadata\">2018;<\/span><span class=\"highwire-cite-metadata-volume highwire-cite-metadata\">8:<\/span><span class=\"highwire-cite-metadata-elocation-id highwire-cite-metadata\">e018835.\u00a0<\/span><span class=\"highwire-cite-metadata-doi highwire-cite-metadata\"><span class=\"label\">doi:<\/span>\u00a010.1136\/bmjopen-2017-018835<\/span><\/a><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1266\" src=\"http:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/Tableau-cost-effectiveness.png\" alt=\"\" width=\"895\" height=\"922\" srcset=\"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/Tableau-cost-effectiveness.png 895w, https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/Tableau-cost-effectiveness-291x300.png 291w, https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/Tableau-cost-effectiveness-768x791.png 768w, https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/Tableau-cost-effectiveness-243x250.png 243w\" sizes=\"auto, (max-width: 895px) 100vw, 895px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>25What\u00a0 is the FreeO2\u00a0value proposition for COPD exacerbation ? Minus [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-freeo2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov\" \/>\n<meta property=\"og:description\" content=\"25What\u00a0 is the FreeO2\u00a0value proposition for COPD exacerbation ? Minus [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxynov\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-30T07:05:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T17:50:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1430\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"camille.burugorri\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"camille.burugorri\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/\"},\"author\":{\"name\":\"camille.burugorri\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/#\\\/schema\\\/person\\\/0052c9ff9b6ce0db719f4e261434e5a4\"},\"headline\":\"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations\",\"datePublished\":\"2018-01-30T07:05:08+00:00\",\"dateModified\":\"2026-01-30T17:50:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/\"},\"wordCount\":85,\"image\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxynov.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/BMJ-2018-3.png\",\"articleSection\":[\"FreeO2\"],\"inLanguage\":\"en-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/\",\"url\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/\",\"name\":\"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.oxynov.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/BMJ-2018-3.png\",\"datePublished\":\"2018-01-30T07:05:08+00:00\",\"dateModified\":\"2026-01-30T17:50:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/#\\\/schema\\\/person\\\/0052c9ff9b6ce0db719f4e261434e5a4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.oxynov.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/BMJ-2018-3.png\",\"contentUrl\":\"https:\\\/\\\/www.oxynov.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/BMJ-2018-3.png\",\"width\":1430,\"height\":1622},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/#website\",\"url\":\"https:\\\/\\\/www.oxynov.com\\\/\",\"name\":\"Oxynov\",\"description\":\"Optimised oxygen therapy at every stage of treatment.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.oxynov.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.oxynov.com\\\/#\\\/schema\\\/person\\\/0052c9ff9b6ce0db719f4e261434e5a4\",\"name\":\"camille.burugorri\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g\",\"caption\":\"camille.burugorri\"},\"url\":\"https:\\\/\\\/www.oxynov.com\\\/en\\\/author\\\/camille-burugorri\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/","og_locale":"en_US","og_type":"article","og_title":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov","og_description":"25What\u00a0 is the FreeO2\u00a0value proposition for COPD exacerbation ? Minus [&hellip;]","og_url":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/","og_site_name":"Oxynov","article_published_time":"2018-01-30T07:05:08+00:00","article_modified_time":"2026-01-30T17:50:36+00:00","og_image":[{"width":1430,"height":1622,"url":"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png","type":"image\/png"}],"author":"camille.burugorri","twitter_card":"summary_large_image","twitter_misc":{"Written by":"camille.burugorri"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#article","isPartOf":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/"},"author":{"name":"camille.burugorri","@id":"https:\/\/www.oxynov.com\/#\/schema\/person\/0052c9ff9b6ce0db719f4e261434e5a4"},"headline":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations","datePublished":"2018-01-30T07:05:08+00:00","dateModified":"2026-01-30T17:50:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/"},"wordCount":85,"image":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png","articleSection":["FreeO2"],"inLanguage":"en-CA"},{"@type":"WebPage","@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/","url":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/","name":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations - Oxynov","isPartOf":{"@id":"https:\/\/www.oxynov.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#primaryimage"},"image":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png","datePublished":"2018-01-30T07:05:08+00:00","dateModified":"2026-01-30T17:50:36+00:00","author":{"@id":"https:\/\/www.oxynov.com\/#\/schema\/person\/0052c9ff9b6ce0db719f4e261434e5a4"},"breadcrumb":{"@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/"]}]},{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#primaryimage","url":"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png","contentUrl":"https:\/\/www.oxynov.com\/wp-content\/uploads\/2018\/01\/BMJ-2018-3.png","width":1430,"height":1622},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxynov.com\/en\/publication-in-the-bmj-of-the-pilot-study-on-the-cost-effectiveness-of-freeo2-in-patients-with-copd-acute-exacerbations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oxynov.com\/en\/"},{"@type":"ListItem","position":2,"name":"Publication in the BMJ of the Pilot Study on the cost-effectiveness of FreeO2 in patients with COPD acute exacerbations"}]},{"@type":"WebSite","@id":"https:\/\/www.oxynov.com\/#website","url":"https:\/\/www.oxynov.com\/","name":"Oxynov","description":"Optimised oxygen therapy at every stage of treatment.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxynov.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-CA"},{"@type":"Person","@id":"https:\/\/www.oxynov.com\/#\/schema\/person\/0052c9ff9b6ce0db719f4e261434e5a4","name":"camille.burugorri","image":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a1b9cae7d5d79c514a2fd50e8fa34c0e0a046d536c27919c93e6669a208ccfc?s=96&d=mm&r=g","caption":"camille.burugorri"},"url":"https:\/\/www.oxynov.com\/en\/author\/camille-burugorri\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/posts\/1635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/comments?post=1635"}],"version-history":[{"count":3,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions"}],"predecessor-version":[{"id":3332,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions\/3332"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/media\/1254"}],"wp:attachment":[{"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/media?parent=1635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/categories?post=1635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxynov.com\/en\/wp-json\/wp\/v2\/tags?post=1635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}